Current cell-based approaches for the treatment of diabetes mellitus

Biotechnology and Genetic Engineering Reviews

Volumn 24, Issue 1, 2007, Pages 281-296

  Rivas Carrillo, Jorge David ^a   Okitsu, Teru ^b   Kobayashi, Naoya ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL BASED APPROACHES; CURRENT CELLS; DIABETES MELLITUS;

B LYMPHOCYTE; CELL FUNCTION; CELL THERAPY; DIABETES MELLITUS; EMBRYO DEVELOPMENT; HUMAN; NONHUMAN; REVIEW;

EID: 35649002016     PISSN: 02648725     EISSN: 20465556     Source Type: Journal    
DOI: 10.1080/02648725.2007.10648104     Document Type: Article

References (54)

1. Ahlgren, U., Pfaff, S.L., Jessell, T.M., Edlund, T., and Edlund, H., 1997. Independent requirement for ISL1 in formation of pancreatic mesenchyme and islet cells. Nature, 385:257–260.
2. Apelqvist, A., Li, H., Sommer, L., Beatus, P., Anderson, D.J., Honjo, T., Hrabe De Angelis, M., Lendahl, U., and Edlund, H., 1999. Notch signalling controls pancreatic cell differentiation. Nature, 400:877–881.
3. Ball, S.G., and Barber, T.M., 2003. Molecular development of the pancreatic beta cell:implications for cell replacement therapy. Trends Endocrinol, Metab, 14:349–355.
4. Blyszczuk, P., Czyz, J., Kania, G., Wagner, M., Roll, U., St-Onge, L., and Wobus, A.M., 2003. Expression of Pax4 in embryonic stem cells promotes differentiation of nestin-positive progenitor and insulin-producing cells. Proc. Natl. Acad. Sci, 100:998–1003. USA
5. Bouwens, L., and Rooman, I., 2005. Regulation of pancreatic beta-cell mass. Physiol Rev, 85:1255–1270.
6. Cras-Meneur, C., Elghazi, L., Czernichow, P., and Scharfmann, R., 2001. Epidermal growth factor increases undifferentiated pancreatic embryonic cells in vitro:a balance between proliferation and differentiation. Diabetes, 50:1571–1579.
7. de la Tour, D., Halvorsen, T., Demeterco, C., Tyrberg, B., Itkin-Ansari, P., Loy, M., Yoo, S.J., Hao, E., Bossie, S., and Levine, F., 2001. Beta-cell differentiation from a human pancreatic cell line in vitro and in vivo. Mol. Endocrinol, 15:476–483.
8. Dor, Y., Brown, J., Martinez, O.I., and Melton, D.A., 2004. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature, 429:41–46.
9. Edlund, H., 2001. Developmental biology of the pancreas. Diabetes, 50 (1):S5–9.
10. Edlund, H., 2002. Pancreatic organogenesis-developmental mechanisms and implications for therapy. Nature Rev. Genet, 3:524–532.
11. Efrat, S., 2002. Cell replacement therapy for type 1 diabetes. Trends Mol. Med, 8:334–339.
12. Elghazi, L., Cras-Meneur, C., Czernichow, P., and Scharfmann, R., 2002. Role for FGFR2IIIb-mediated signals in controlling pancreatic endocrine progenitor cell proliferation. Proc. Natl. Acad. Sci. USA, 99:3884–3889.
13. Fujikawa, T., Oh, S.H., Pi, L., Hatch, H.M., Shupe, T., and Petersen, B.E., 2005. Teratoma formation leads to failure of treatment for type I diabetes using embryonic stem cell-derived insulin-producing cells. Am. J. Pathol, 166:1781–1791.
14. Georgia, S., and Bhushan, A., 2004. Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. J. Clin. Invest, 114:963–968.
15. Gu, G., Dubauskaite, J., and Melton, D.A., 2002. Direct evidence for the pancreatic lineage:NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development, 129:2447–2457.
16. Halban, P.A., 2004. Cellular sources of new pancreatic beta cells and therapeutic implications for regenerative medicine. Nature Cell. Biol, 6:1021–1025.
17. Halban, P.A., Kahn, S.E., Lernmark, A., and Rhodes, C.J., 2001. Gene and cell-replacement therapy in the treatment of type 1 diabetes:how high must the standards be set?. Diabetes, 50:2181–2191.
18. Harmon, E.B., Apelqvist, A.A., Smart, N.G., Gu, X., Osborne, D.H., and Kim, S.K., 2004. GDF11 modulates NGN3+ islet progenitor cell number and promotes beta-cell differentiation in pancreas development. Development, 131:6163–6174.
19. Hart, A., Papadopoulou, S., and Edlund, H., 2003. Fgf10 maintains notch activation, stimulates proliferation, and blocks differentiation of pancreatic epithelial cells. Dev. Dyn, 228:185–193.
20. Itkin-Ansari, P., Geron, I., Hao, E., Demeterco, C., Tyrberg, B., and Levine, F., 2003. Cell-based therapies for diabetes:progress towards a transplantable human beta cell line. Ann. N.Y. Acad. Sci, 1005:138–147.
21. Jensen, J., 2004. Gene regulatory factors in pancreatic development. Dev. Dyn, 229:176–200.
22. Jensen, J., Heller, R.S., Funder-Nielsen, T., Pedersen, E.E., Lindsell, C., Weinmaster, G., Madsen, O.D., and Serup, P., 2000. Independent development of pancreatic alpha-and beta-cells from neurogenin3-expressing precursors:a role for the notch pathway in repression of premature differentiation. Diabetes, 49:163–176.
23. Jiang, Y., Jahagirdar, B.N., Reinhardt, R.L., Schwartz, R.E., Keene, C.D., Ortiz-Gonzalez, X.R., Reyes, M., Lenvik, T., Lund, T., Blackstad, M., Du, J., Aldrich, S., Lisberg, A., Low, W. C., Largaespada, D.A., and Verfaillie, C.M., 2002. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature, 418:41–49.
24. Kania, G., Blyszczuk, P., and Wobus, A.M., 2004. The generation of insulin-producing cells from embryonic stem cells-a discussion of controversial findings. J. Dev. Biol, 48:1061–4.
25. Kobayashi, N., Fujiwara, T., Westerman, K.A., Inoue, Y., Sakaguchi, M., Noguchi, H., Miyazaki, M., Cai, J., Tanaka, N., Fox, I.J., and Leboulch, P., 2000a. Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science, 287:1258–1262.
26. Kobayashi, N., Noguchi, H., Watanabe, T., Matsumura, T., Totsugawa, T., Fujiwara, T., Taguchi, T., Urata, H., Kishimoto, N., Hayashi, N., Nakaji, S., Westerman, K.A., Leboulch, P., Murakami, T., and Tanaka, N., 2000b. A new approach to develop a biohybrid artificial liver using a tightly regulated human hepatocyte cell line. Hum. Cell, 13:229–235.
27. Kulkarni, R.N., 2004. The islet beta-cell. Int. J. Biochem. Cell Biol, 36:365–371.
28. Lechner, A., and Habener, J.F., 2003. Stem/progenitor cells derived from adult tissues:potential for the treatment of diabetes mellitus. Am. J. Physiol. Endocrinol. Metab, 284:E259–266.
29. Lee, C.S., De Leon, D.D., Kaestner, K.H., and Stoffers, D.A., 2006. Regeneration of pancreatic islets after partial pancreatectomy in mice does not involve the reactivation of neurogenin-3. Diabetes, 55:269–272.
30. Lumelsky, N., Blondel, O., Laeng, P., Velasco, I., Ravin, R., and McKay, R., 2001. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science, 292:1389–1394.
31. Maruyama, M., Kobayashi, N., Westerman, K.A., Sakaguchi, M., Allain, J.E., Totsugawa, T., Okitsu, T., Fukazawa, T., Weber, A., Stolz, D.B., Leboulch, P., and Tanaka, N., 2004. Establishment of a highly differentiated immortalized human cholangiocyte cell line with SV40T and hTERT. Transplantation, 77:446–451.
32. Matsumura, T., Takesue, M., Westerman, K.A., Okitsu, T., Sakaguchi, M., Fukazawa, T., Totsugawa, T., Noguchi, H., Yamamoto, S., Stolz, D.B., Tanaka, N., Leboulch, P., and Kobayashi, N., 2004. Establishment of an immortalized human-liver endothelial cell line with SV40T and hTERT. Transplantation, 77:1357–1365.
33. Mitanchez, D., Doiron, B., Chen, R., and Kahn, A., 1997. Glucose-stimulated genes and prospects of gene therapy for type I diabetes. Endocr. Rev, 18:520–540.
34. Miyazaki, S., Yamato, E., and Miyazaki, J., 2004. Regulated expression of pdx-1 promotes in vitro differentiation of insulin-producing cells from embryonic stem cells. Diabetes, 53:1030–1037.
35. Muzzin, P., Eisensmith, R.C., Copeland, K.C., and Woo, S.L., 1997. Hepatic insulin gene expression as treatment for type 1 diabetes mellitus in rats. Mol. Endocrinol, 11:833–837.
36. Narushima, M., Kobayashi, N., Okitsu, T., Tanaka, Y., Li, S.A., Chen, Y., Miki, A., Tanaka, K., Nakaji, S., Takei, K., Gutierrez, A.S., Rivas-Carrillo, J.D., Navarro-Alvarez, N., Jun, H.S., Westerman, K.A., Noguchi, H., Lakey, J.R., Leboulch, P., Tanaka, N., and Yoon, J.W., 2005. A human beta-cell line for transplantation therapy to control type 1 diabetes. Nature Biotechnology, 23:1274–1282.
37. Nielsen, J.H., Galsgaard, E.D., Moldrup, A., Friedrichsen, B.N., Billestrup, N., Hansen, J.A., Lee, Y.C., and Carlsson, C., 2001. Regulation of beta-cell mass by hormones and growth factors. Diabetes, 50 (1):S25–29.
38. Nir, T., and Dor, Y., 2005. How to make pancreatic beta cells-prospects for cell therapy in diabetes. Curr. Opin. Biotechnol, 16:524–529.
39. Ohneda, K., Ee, H., and German, M., 2000. Regulation of insulin gene transcription. Semin. Cell Dev. Biol, 11:227–233.
40. Okitsu, T., Kobayashi, N., Jun, H.S., Shin, S., Kim, S.J., Han, J., Kwon, H., Sakaguchi, M., Totsugawa, T., Kohara, M., Westerman, K.A., Tanaka, N., Leboulch, P., and Yoon, J.W., 2004. Transplantation of reversibly immortalized insulin-secreting human hepatocytes controls diabetes in pancreatectomized pigs. Diabetes, 53:105–112.
41. Rajagopal, J., Anderson, W.J., Kume, S., Martinez, O.I., and Melton, D.A., 2003. Insulin staining of ES cell progeny from insulin uptake. Science, 299:363
42. Ryan, E.A., Paty, B.W., Senior, P.A., Bigam, D., Alfadhli, E., Kneteman, N.M., Lakey, J.R., and Shapiro, A.M., 2005. Five-year follow-up after clinical islet transplantation. Diabetes, 54:2060–2069.
43. Sander, M., and German, M.S., 1997. The beta cell transcription factors and development of the pancreas. J. Mol. Med, 75:327–340.
44. Scharfmann, R., 2000. Control of early development of the pancreas in rodents and humans:implications of signals from the mesenchyme. Diabetologia, 43:1083–1092.
45. Seaberg, R.M., Smukler, S.R., Kieffer, T.J., Enikolopov, G., Asghar, Z., Wheeler, M.B., Korbutt, G., and van der Kooy, D., 2004. Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages. Nature Biotechnology, 22:1115–1124.
46. Shibata, N., Watanabe, T., Okitsu, T., Sakaguchi, M., Takesue, M., Kunieda, T., Omoto, K., Yamamoto, S., Tanaka, N., and Kobayashi, N., 2003. Establishment of an immortalized human hepatic stellate cell line to develop antifibrotic therapies. Cell Transplant, 12:499–507.
47. Sipione, S., Eshpeter, A., Lyon, J.G., Korbutt, G.S., and Bleackley, R.C., 2004. Insulin expressing cells from differentiated embryonic stem cells are not beta cells. Diabetologia, 47:499–508.
48. Soria, B., 2001. In-vitro differentiation of pancreatic beta-cells. Differentiation, 68:205–219.
49. Soria, B., Roche, E., Berna, G., Leon-Quinto, T., Reig, J.A., and Martin, F., 2000. Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes, 49:157–162.
50. Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J., Marshall, V.S., and Jones, J.M., 1998. Embryonic stem cell lines derived from human blastocysts. Science, 282:1145–1147.
51. Thule, P.M., and Liu, J.M., 2000. Regulated hepatic insulin gene therapy of STZ-diabetic rats. Gene Ther, 7:1744–1752.
52. Tiedge, M., Lortz, S., Drinkgern, J., and Lenzen, S., 1997. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes, 46:1733–1742.
53. Wells, J.M., and Melton, D.A., 1999. Vertebrate endoderm development. Annu Rev Cell Dev Biol, 15, 393–410 (2000) Early mouse endoderm is patterned by soluble factors from adjacent germ layers. Development, 127:1563–1572.
54. Zulewski, H., Abraham, E.J., Gerlach, M.J., Daniel, P.B., Moritz, W., Muller, B., Vallejo, M., Thomas, M.K., and Habener, J.F., 2001. Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes, 50:521–533.